Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Deuruxolitinib effectively regrows hair in adults with alopecia areata and is well tolerated.

Baricitinib-loaded EVs help hair regrowth in alopecia areata by reducing inflammation and promoting hair follicle regeneration.

Tralokinumab successfully treated alopecia areata in a patient with atopic dermatitis.

Combining delgocitinib ointment with excimer laser can effectively treat severe alopecia areata.

Janus kinase inhibitors effectively treat alopecia areata but may cause relapses and have long-term safety concerns.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Baricitinib reduces inflammation and improves cell health in premature aging cells.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

CDK4/6 inhibitors can protect hair cells from chemotherapy damage.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

Tofacitinib taken by mouth helps treat hair loss in children.

Tacrolimus is effective for various skin conditions with fewer side effects than cyclosporine.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Ruxolitinib cream may help treat severe hair loss in children.

Tacrolimus is an effective treatment for several skin conditions with fewer side effects than cyclosporine.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Upadacitinib improves life quality for Alopecia Areata patients without worsening skin issues.

Tofacitinib helped regrow hair in a woman with alopecia areata.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Early genetic testing and JAK inhibitors can help treat systemic inflammation in SAVI patients.

ZD1839 can cause skin issues like acne and hair changes.